Nancy Wei

729 total citations
20 papers, 465 citations indexed

About

Nancy Wei is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Dermatology. According to data from OpenAlex, Nancy Wei has authored 20 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in Nancy Wei's work include Diabetes Management and Research (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diabetes Treatment and Management (6 papers). Nancy Wei is often cited by papers focused on Diabetes Management and Research (6 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers) and Diabetes Treatment and Management (6 papers). Nancy Wei collaborates with scholars based in United States, Netherlands and Switzerland. Nancy Wei's co-authors include David M. Nathan, Hui Zheng, Deborah J. Wexler, Mark Lebwohl, David M. Nathan, Richard W. Grant, Huang-Chun Tseng, Huib Ovaa, Hidde L. Ploegh and Li‐Huei Tsai and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Diabetes Care.

In The Last Decade

Nancy Wei

19 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Wei United States 13 162 87 70 61 56 20 465
Zhu Ming China 12 73 0.5× 130 1.5× 76 1.1× 86 1.4× 25 0.4× 25 581
Mario Šekerija Croatia 13 103 0.6× 70 0.8× 83 1.2× 38 0.6× 8 0.1× 53 487
Chiz-Tzung Chang Taiwan 15 55 0.3× 197 2.3× 129 1.8× 47 0.8× 28 0.5× 33 650
Meghan Kapp United States 10 37 0.2× 66 0.8× 73 1.0× 20 0.3× 236 4.2× 32 488
Hui‐Lee Wong United States 10 81 0.5× 124 1.4× 27 0.4× 9 0.1× 42 0.8× 31 451
Diego Chambergo‐Michilot Peru 12 31 0.2× 46 0.5× 77 1.1× 13 0.2× 29 0.5× 62 372
L. Eissing Germany 10 68 0.4× 105 1.2× 80 1.1× 222 3.6× 24 0.4× 11 648
Madunil Anuk Niriella Sri Lanka 14 144 0.9× 27 0.3× 128 1.8× 18 0.3× 57 1.0× 85 650
Didier Morel United States 11 205 1.3× 49 0.6× 23 0.3× 7 0.1× 13 0.2× 23 417
J McKiernan Ireland 12 79 0.5× 88 1.0× 111 1.6× 62 1.0× 30 0.5× 34 472

Countries citing papers authored by Nancy Wei

Since Specialization
Citations

This map shows the geographic impact of Nancy Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Wei more than expected).

Fields of papers citing papers by Nancy Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Wei. The network helps show where Nancy Wei may publish in the future.

Co-authorship network of co-authors of Nancy Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Wei. A scholar is included among the top collaborators of Nancy Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Wei. Nancy Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Nancy, et al.. (2024). Ruxolitinib cream for the treatment of granuloma annulare. JAAD Case Reports. 50. 62–64. 7 indexed citations
2.
Wei, Nancy, et al.. (2022). Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study. Journal of the American Academy of Dermatology. 88(5). 1182–1183. 2 indexed citations
3.
Wei, Nancy, et al.. (2022). Case 23-2022: A 49-Year-Old Man with Hypoglycemia. New England Journal of Medicine. 387(4). 356–365. 2 indexed citations
4.
Wei, Nancy, et al.. (2021). “COVID arm”: A reaction to the Moderna vaccine. JAAD Case Reports. 10. 92–95. 41 indexed citations
5.
Wei, Nancy, et al.. (2021). New onset and exacerbation of psoriasis after COVID-19 vaccination. JAAD Case Reports. 19. 74–77. 26 indexed citations
6.
Ungar, Benjamin, Jacob W. Glickman, Celina Dubin, et al.. (2021). COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab. The Journal of Allergy and Clinical Immunology In Practice. 10(1). 134–142. 29 indexed citations
7.
Landman, Adam, Lee H. Schwamm, Shuhan He, et al.. (2020). Digital triage: Novel strategies for population health management in response to the COVID-19 pandemic. Healthcare. 8(4). 100493–100493. 66 indexed citations
8.
Wright, Adam, Tarik K. Alkasab, Amy L. Miller, et al.. (2019). Importance of clinical decision support system response time monitoring: a case report. Journal of the American Medical Informatics Association. 26(11). 1375–1378. 5 indexed citations
9.
Fan, WuQiang, Hui Zheng, Nancy Wei, & David M. Nathan. (2018). Estimating HbA1c from timed Self-Monitored Blood Glucose values. Diabetes Research and Clinical Practice. 141. 56–61. 12 indexed citations
10.
Wei, Nancy, Jessica Pan, Rodica Pop‐Busui, et al.. (2014). Altered sphingoid base profiles in type 1 compared to type 2 diabetes. Lipids in Health and Disease. 13(1). 161–161. 33 indexed citations
11.
Wei, Nancy, David M. Nathan, & Deborah J. Wexler. (2014). Glycemic Control After Hospital Discharge in Insulin-Treated Type 2 Diabetes: A Randomized Pilot Study of Daily Remote Glucose Monitoring. Endocrine Practice. 21(2). 115–121. 15 indexed citations
12.
Segrè, Ayellet V., et al.. (2014). Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk. Diabetes. 64(4). 1470–1483. 23 indexed citations
13.
Wei, Nancy, Hui Zheng, & David M. Nathan. (2014). Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals. Diabetes Care. 37(4). 1048–1051. 63 indexed citations
14.
Wei, Nancy, Deborah J. Wexler, David M. Nathan, & Richard W. Grant. (2012). Intensification of diabetes medication and risk for 30‐day readmission. Diabetic Medicine. 30(2). e56–62. 43 indexed citations
15.
Wei, Nancy, Richard W. Grant, David M. Nathan, & Deborah J. Wexler. (2012). Effect of Hospital Admission on Glycemic Control One Year after Discharge. Endocrine Practice. 1(-1). 1–22.
16.
Wei, Nancy & Deborah J. Wexler. (2012). Perioperative Glucose Management. PubMed. 1(4). e508–e519. 1 indexed citations
17.
Kroh, Heather K., Peter Panizzi, Svetlana Tchaikovski, et al.. (2011). Active Site-labeled Prothrombin Inhibits Prothrombinase in Vitro and Thrombosis in Vivo. Journal of Biological Chemistry. 286(26). 23345–23356. 13 indexed citations
18.
Phitayakorn, Roy, William C. Faquin, Nancy Wei, Giuseppe Barbesino, & Antonia E. Stephen. (2011). Thyroid-Associated Paragangliomas. Thyroid. 21(7). 725–733. 29 indexed citations
19.
Wei, Nancy & Deborah J. Wexler. (2011). Basal-Bolus Insulin Protocols Enter the Computer Age. Current Diabetes Reports. 12(1). 119–126. 16 indexed citations
20.
Tseng, Huang-Chun, Huib Ovaa, Nancy Wei, Hidde L. Ploegh, & Li‐Huei Tsai. (2005). Phosphoproteomic Analysis with a Solid-Phase Capture-Release-Tag Approach. Chemistry & Biology. 12(7). 769–777. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhu Ming Breakdown of academic impact, for papers by Mario Šekerija Breakdown of academic impact, for papers by Chiz-Tzung Chang Breakdown of academic impact, for papers by Meghan Kapp Breakdown of academic impact, for papers by Hui‐Lee Wong Breakdown of academic impact, for papers by Diego Chambergo‐Michilot Breakdown of academic impact, for papers by L. Eissing Breakdown of academic impact, for papers by Madunil Anuk Niriella Breakdown of academic impact, for papers by Didier Morel Breakdown of academic impact, for papers by J McKiernan
Rankless by CCL
2026